AR066457A1 - Derivados de imidazol, procesos de obtencion, composiciones farmaceuticas y usos. - Google Patents

Derivados de imidazol, procesos de obtencion, composiciones farmaceuticas y usos.

Info

Publication number
AR066457A1
AR066457A1 ARP080101912A ARP080101912A AR066457A1 AR 066457 A1 AR066457 A1 AR 066457A1 AR P080101912 A ARP080101912 A AR P080101912A AR P080101912 A ARP080101912 A AR P080101912A AR 066457 A1 AR066457 A1 AR 066457A1
Authority
AR
Argentina
Prior art keywords
alkyl
halogen
term
aryl
group
Prior art date
Application number
ARP080101912A
Other languages
English (en)
Spanish (es)
Original Assignee
Bial Portela & Ca Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38198874&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR066457(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bial Portela & Ca Sa filed Critical Bial Portela & Ca Sa
Publication of AR066457A1 publication Critical patent/AR066457A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Rheumatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ARP080101912A 2007-05-08 2008-05-06 Derivados de imidazol, procesos de obtencion, composiciones farmaceuticas y usos. AR066457A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0708818.0A GB0708818D0 (en) 2007-05-08 2007-05-08 Compounds

Publications (1)

Publication Number Publication Date
AR066457A1 true AR066457A1 (es) 2009-08-19

Family

ID=38198874

Family Applications (2)

Application Number Title Priority Date Filing Date
ARP080101912A AR066457A1 (es) 2007-05-08 2008-05-06 Derivados de imidazol, procesos de obtencion, composiciones farmaceuticas y usos.
ARP180102520A AR112789A2 (es) 2007-05-08 2018-09-05 COMPUESTOS INHIBIDORES DE DOPAMINA-b-HIDROXILASA

Family Applications After (1)

Application Number Title Priority Date Filing Date
ARP180102520A AR112789A2 (es) 2007-05-08 2018-09-05 COMPUESTOS INHIBIDORES DE DOPAMINA-b-HIDROXILASA

Country Status (29)

Country Link
US (5) US8481582B2 (OSRAM)
EP (1) EP2155731B1 (OSRAM)
JP (1) JP5559677B2 (OSRAM)
KR (1) KR101598482B1 (OSRAM)
CN (1) CN101687858B (OSRAM)
AR (2) AR066457A1 (OSRAM)
AT (1) ATE499367T1 (OSRAM)
AU (1) AU2008246443B2 (OSRAM)
BR (1) BRPI0811275B8 (OSRAM)
CA (1) CA2686387C (OSRAM)
CL (1) CL2008001321A1 (OSRAM)
CY (1) CY1111517T1 (OSRAM)
DE (1) DE602008005141D1 (OSRAM)
DK (1) DK2155731T3 (OSRAM)
ES (1) ES2360841T3 (OSRAM)
GB (1) GB0708818D0 (OSRAM)
HR (1) HRP20110253T1 (OSRAM)
IL (1) IL201921A (OSRAM)
MX (1) MX2009012041A (OSRAM)
NO (1) NO20093275L (OSRAM)
NZ (1) NZ580962A (OSRAM)
PL (1) PL2155731T3 (OSRAM)
RS (1) RS51692B (OSRAM)
RU (1) RU2501796C2 (OSRAM)
SI (1) SI2155731T1 (OSRAM)
TW (1) TWI458722B (OSRAM)
UA (1) UA104844C2 (OSRAM)
WO (1) WO2008136695A1 (OSRAM)
ZA (1) ZA200908612B (OSRAM)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0708818D0 (en) 2007-05-08 2007-06-13 Portela & Ca Sa Compounds
JP6075621B2 (ja) * 2010-08-10 2017-02-08 塩野義製薬株式会社 新規複素環誘導体およびそれらを含有する医薬組成物
KR101941467B1 (ko) 2010-12-22 2019-01-23 바이알 - 포르텔라 앤드 씨에이 에스에이 결정형 및 이들의 제조방법
EP2726454B1 (en) 2011-06-29 2018-01-24 Bial-Portela & CA, S.A. Process
PL2919780T3 (pl) 2012-11-14 2019-01-31 Bial - Portela & Ca., S.A. Pochodne 1,3-dihydroimidazolo-2-tionu do zastosowania w leczeniu tętniczego nadciśnienia płucnego i uszkodzenia płuc
CN103356671B (zh) * 2013-06-24 2015-11-25 顾祥茂 Houttuynoid C在制备治疗或预防慢性心衰的药物中的应用
GB201316410D0 (en) 2013-09-13 2013-10-30 Bial Portela & Ca Sa Processes for preparing peripherally-selective inhibitors of dopamine-?-hydroxylase and intermediates for use therein
JOP20190049A1 (ar) * 2016-09-23 2019-03-20 Bial Portela & C? S A مثبطات دوبامين-b-هيدروكسيلاز
WO2019055590A1 (en) 2017-09-13 2019-03-21 Amgen Inc. SARCOMERIC BISAMIDE ACTIVATOR COMPOUNDS AND USES THEREOF
SG11202004231YA (en) 2017-12-04 2020-06-29 BIAL PORTELA & Cª S A Dopamine-β-hydroxylase inhibitors
GB201810395D0 (en) * 2018-06-25 2018-08-08 Bial Portela & Ca Sa Formulations comprising dopamine-beta-hydroxylase inhibitors and methods for their preparation
SG11202104423XA (en) * 2018-11-12 2021-05-28 Immunogen Inc Methods of preparing cytotoxic benzodiazepine derivatives
GB201908044D0 (en) 2019-06-05 2019-07-17 Bial Portela & Ca Sa Dopamine-B-Hydroxylase inhibitors
MX2023008573A (es) * 2021-01-26 2023-08-08 Jiangsu Yahong Meditech Co Ltd Modulador de via, composicion farmaceutica que tiene la misma, uso y metodo terapeutico que utiliza la misma.

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4217347A (en) * 1977-12-27 1980-08-12 E. R. Squibb & Sons, Inc. Method of treating hypertension and medicaments therefor
US4962128A (en) * 1989-11-02 1990-10-09 Pfizer Inc. Method of treating anxiety-related disorders using sertraline
US5298497A (en) * 1990-05-15 1994-03-29 E. R. Squibb & Sons, Inc. Method for preventing onset of hypertension employing a cholesterol lowering drug
CZ290082B6 (cs) 1994-04-26 2002-05-15 Syntex (U. S. A.) Inc. Benzocykloalkylazolthionové deriváty, farmaceutický prostředek je obsahující, způsob jejich přípravy a meziprodukty přípravy
AR032711A1 (es) 2001-02-21 2003-11-19 Solvay Pharm Bv Derivados de fenilpiperazina, un metodo para la preparacion de los mismos y una composicion farmaceutica que los contiene
GB2393958A (en) * 2002-10-11 2004-04-14 Portela & Ca Sa Peripherally-selective imidazole inhibitors of dopamine-beta-hydroxylase
US7125904B2 (en) 2002-10-11 2006-10-24 Portela & C.A., S.A. Peripherally-selective inhibitors of dopamine-β-hydroxylase and method of their preparation
GB0708818D0 (en) 2007-05-08 2007-06-13 Portela & Ca Sa Compounds

Also Published As

Publication number Publication date
CN101687858B (zh) 2012-12-26
RU2009145270A (ru) 2011-06-20
MX2009012041A (es) 2010-02-18
CN101687858A (zh) 2010-03-31
HRP20110253T1 (hr) 2011-05-31
SI2155731T1 (sl) 2011-05-31
TWI458722B (zh) 2014-11-01
ZA200908612B (en) 2010-11-24
US20190322648A1 (en) 2019-10-24
AR112789A2 (es) 2019-12-11
ES2360841T3 (es) 2011-06-09
GB0708818D0 (en) 2007-06-13
DE602008005141D1 (de) 2011-04-07
CA2686387C (en) 2015-06-30
KR20100017546A (ko) 2010-02-16
AU2008246443A1 (en) 2008-11-13
US20100137390A1 (en) 2010-06-03
NO20093275L (no) 2010-02-04
NZ580962A (en) 2012-05-25
US9630951B2 (en) 2017-04-25
BRPI0811275B1 (pt) 2020-01-07
CL2008001321A1 (es) 2008-12-26
UA104844C2 (uk) 2014-03-25
RS51692B (sr) 2011-10-31
WO2008136695A1 (en) 2008-11-13
IL201921A0 (en) 2010-06-16
US20130345275A1 (en) 2013-12-26
JP5559677B2 (ja) 2014-07-23
HK1142898A1 (en) 2010-12-17
US20210261533A1 (en) 2021-08-26
ATE499367T1 (de) 2011-03-15
AU2008246443B2 (en) 2013-07-11
CY1111517T1 (el) 2015-08-05
TW200918525A (en) 2009-05-01
PL2155731T3 (pl) 2011-07-29
AU2008246443A8 (en) 2010-01-07
RU2501796C2 (ru) 2013-12-20
KR101598482B1 (ko) 2016-02-29
CA2686387A1 (en) 2008-11-13
IL201921A (en) 2013-11-28
BRPI0811275A2 (pt) 2014-12-23
BRPI0811275B8 (pt) 2021-05-25
DK2155731T3 (da) 2011-05-02
EP2155731A1 (en) 2010-02-24
US8481582B2 (en) 2013-07-09
US20170369478A1 (en) 2017-12-28
JP2010526136A (ja) 2010-07-29
EP2155731B1 (en) 2011-02-23

Similar Documents

Publication Publication Date Title
AR066457A1 (es) Derivados de imidazol, procesos de obtencion, composiciones farmaceuticas y usos.
AR091790A1 (es) Derivados de isoquinolin-1-ona y sus usos
AR096979A1 (es) Derivados de pirrol, su procedimiento de preparación y las composiciones farmacéuticas que los contienen
AR067886A1 (es) Derivados de acido azabifenilaminobenzoico
AR099913A1 (es) Derivados de indolizina, su procedimiento de preparación y las composiciones farmacéuticas que los contienen
AR061739A1 (es) Nuevos derivados naftalenicos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen
AR083180A1 (es) Amidas de oxopiperazina-azetidina y amidas oxodiazepina-azetidina como inhibidores de monoacilglicerol lipasa
AR065093A1 (es) Compuestos farmacéuticos inhibidores de la biosintesis de leucotrienos
AR074358A1 (es) Derivados de pirazina como inhibidores de la fosfodiesterasa 10
AR063454A1 (es) Derivados acetamida de diazepan como inhibidores selectivos de 11 beta - hsd1. procesos de obtencion y composiciones farmaceuticas.
AR061994A1 (es) Uso de derivados de imidazol activadores de ampk, su proceso de preparacion y composiciones farmaceuticas que los comprenden
AR033379A1 (es) Compuestos de difenilurea, procedimiento para su preparacion y composiciones farmaceuticas que los contienen
NI200900134A (es) Derivados de imidazol como inhibidores de proteína de huso de cinesina (eg-5).
PE20140968A1 (es) Derivados de benzamida sustituida
AR068376A1 (es) Amidas heterociclicas utiles para inhibir la via hedgehog.
AR053092A1 (es) Compuestos derivados de acido fenoxiacetico y compuestos intermediarios de sintesis
AR070188A1 (es) Derivados de sulfonamidas sustituidas
AR086036A1 (es) DERIVADOS DE ETINILO COMO MODULADORES ALOSTERICOS POSITIVOS DE (mGluR5)
AR061835A1 (es) Derivados tetraciclicos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen
AR079077A1 (es) Derivados de piridino-piridinonas, su preparacion y su aplicacion en terapeutica de enfermedades mediadas por la tirosina quinasa
AR041883A1 (es) Compuestos de piridopirimidinona, procedimiento para su preparacion y composiciones farmaceuticas que los contienen
AR063374A1 (es) Derivados de benzoxazina y sus usos
AR086037A1 (es) Derivados de pirazolidin-3-ona
CY1117212T1 (el) Εθυνυλο παραγωγα ως μεταβοτροπικοι ρυθμιστες του υποδοχεα γλουταμινικου
HRP20080097T5 (en) Piperazine derivatives and their use as serotonin reuptake inhibitors or as neurokinin antagonists

Legal Events

Date Code Title Description
FC Refusal